Barclays’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-65
| Closed | – | – | 6779 |
|
|
2019
Q4 | $0 | Hold |
65
| – | – | ﹤0.01% | 7162 |
|
|
2019
Q3 | $0 | Sell |
65
-22,307
| -100% | -$15.1K | ﹤0.01% | 7425 |
|
|
2019
Q2 | $20K | Buy |
22,372
+17,763
| +385% | +$27.8K | ﹤0.01% | 6414 |
|
|
2019
Q1 | $11K | Buy |
4,609
+4,544
| +6,991% | +$12.3K | ﹤0.01% | 6540 |
|
|
2018
Q4 | $0 | Sell |
65
-5,782
| -99% | -$51K | ﹤0.01% | 7653 |
|
|
2018
Q3 | $87K | Buy |
5,847
+4,720
| +419% | +$75K | ﹤0.01% | 5693 |
|
|
2018
Q2 | $17K | Sell |
1,127
-2,207
| -66% | -$37.5K | ﹤0.01% | 6292 |
|
|
2018
Q1 | $63K | Buy |
3,334
+2,536
| +318% | +$44.3K | ﹤0.01% | 5728 |
|
|
2017
Q4 | $14K | Sell |
798
-6,470
| -89% | -$137K | ﹤0.01% | 6434 |
|
|
2017
Q3 | $162K | Buy |
+7,268
| New | +$160K | ﹤0.01% | 4602 |
|